- Home
- QCRH vs STAA Comparison
QCRH vs STAA Comparison
Compare QCRH & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QCRH
- STAA
- Stock Information
- Founded
- QCRH 1993
- STAA 1982
- Country
- QCRH United States
- STAA United States
- Employees
- QCRH N/A
- STAA N/A
- Industry
- QCRH Major Banks
- STAA Ophthalmic Goods
- Sector
- QCRH Finance
- STAA Health Care
- Exchange
- QCRH Nasdaq
- STAA Nasdaq
- Market Cap
- QCRH 1.3B
- STAA 1.4B
- IPO Year
- QCRH 1993
- STAA N/A
- Fundamental
- Price
- QCRH $79.25
- STAA $27.16
- Analyst Decision
- QCRH Buy
- STAA Hold
- Analyst Count
- QCRH 3
- STAA 8
- Target Price
- QCRH $88.83
- STAA $22.50
- AVG Volume (30 Days)
- QCRH 85.6K
- STAA 667.8K
- Earning Date
- QCRH 10-22-2025
- STAA 10-29-2025
- Dividend Yield
- QCRH 0.30%
- STAA N/A
- EPS Growth
- QCRH N/A
- STAA N/A
- EPS
- QCRH 6.63
- STAA N/A
- Revenue
- QCRH $322,873,000.00
- STAA $224,449,000.00
- Revenue This Year
- QCRH N/A
- STAA N/A
- Revenue Next Year
- QCRH $14.12
- STAA $27.24
- P/E Ratio
- QCRH $11.89
- STAA N/A
- Revenue Growth
- QCRH N/A
- STAA N/A
- 52 Week Low
- QCRH $60.83
- STAA $13.50
- 52 Week High
- QCRH $96.08
- STAA $38.60
- Technical
- Relative Strength Index (RSI)
- QCRH 59.46
- STAA 56.68
- Support Level
- QCRH $76.54
- STAA $26.98
- Resistance Level
- QCRH $79.50
- STAA $28.13
- Average True Range (ATR)
- QCRH 1.83
- STAA 0.47
- MACD
- QCRH -0.22
- STAA -0.35
- Stochastic Oscillator
- QCRH 80.05
- STAA 12.86
About QCRH QCR Holdings Inc.
QCR Holdings Inc is a multi-bank holding company. The bank operates through segments namely Commercial Banking, Wealth Management, and all other segments. The commercial bank segment is geographically divided by markets namely Quad City Bank & Trust (QCBT), Cedar Rapids Bank & Trust (CRBT), Community State Bank (CSB) and Guaranty Bank (GB). It generates revenue in the form of interest.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.